|
FUT8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.770800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.714200E-01 |
| Normal-vs-Stage2 |
5.246600E-01 |
| Normal-vs-Stage3 |
3.263800E-01 |
| Normal-vs-Stage4 |
5.045700E-02 |
| Stage1-vs-Stage2 |
8.490000E-01 |
| Stage1-vs-Stage3 |
1.102000E-01 |
| Stage1-vs-Stage4 |
1.564280E-02 |
| Stage2-vs-Stage3 |
1.719160E-01 |
| Stage2-vs-Stage4 |
2.776300E-02 |
| Stage3-vs-Stage4 |
2.538800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.198800E-01 |
| Normal-vs-AfricanAmerican |
4.062000E-01 |
| Normal-vs-Asian |
2.861200E-01 |
| Caucasian-vs-AfricanAmerican |
4.956400E-01 |
| Caucasian-vs-Asian |
1.383230E-01 |
| AfricanAmerican-vs-Asian |
2.775200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.815370E-01 |
| Normal-vs-Female |
2.742400E-01 |
| Male-vs-Female |
4.084400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.590600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.982400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.571400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.817000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.600800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.324400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.587000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.840400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.636000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.771600E-01 |
| Normal-vs-Grade 2 |
5.865400E-01 |
| Normal-vs-Grade 3 |
6.739400E-01 |
| Normal-vs-Grade 4 |
1.480330E-02 |
| Grade 1-vs-Grade 2 |
7.623000E-01 |
| Grade 1-vs-Grade 3 |
4.534200E-01 |
| Grade 1-vs-Grade 4 |
1.947810E-02 |
| Grade 2-vs-Grade 3 |
2.815200E-01 |
| Grade 2-vs-Grade 4 |
6.138200E-03 |
| Grade 3-vs-Grade 4 |
2.132200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.078100E-03 |
| Normal-vs-ccB subtype |
1.362010E-02 |
| ccA subtype-vs-ccB subtype |
1.82119999969643E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.223800E-01 |
| Normal-vs-N1 |
1.037180E-01 |
| N0-vs-N1 |
3.245000E-01 |
|
|
